Breath-holding radiotherapy for stage III lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a new way of giving radiation to the lungs that aims to protect healthy lung tissue and improve breathing after treatment. It is for people with stage III lung cancer who are about to start radiation therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You have stage III non-small cell lung cancer
- You are scheduled to receive radiation therapy to the chest, with or without other treatments like chemo or immunotherapy
- You are able to hold your breath for at least 15 seconds
- You have not had radiation therapy to the lung before
- You have not had lung surgery in the past year and are not planning to have it soon
- You do not have metal implants or stents in your chest
- You do not have severe chronic obstructive pulmonary disease (COPD) or interstitial lung disease
- You are not pregnant or planning to become pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a newer, more precise way of giving radiation for lung cancer tumors that are near the center of the chest. The goal is to see if using a smaller treatment area can reduce side effects while still killing the cancer.
This trial looks at adding two immunotherapy drugs to radiation and chemotherapy for people with stage 3 lung cancer that cannot be removed by surgery. It compares giving immunotherapy during radiation versus giving it after radiation, to see which way may help control the cancer better.
This trial tests if using a simple breathing exercise device (called an incentive spirometer) during chemo and radiation for advanced lung cancer can help improve breathing outcomes and overall recovery.
This trial tests whether focusing radiation only on the main tumor (not the surrounding area) is safe and effective for people with stage 3 lung cancer that cannot be removed with surgery. It aims to reduce side effects while keeping the treatment working.
This trial tests whether a special type of focused radiation therapy can effectively treat advanced non-small cell lung cancer (the most common type) as an upfront treatment. It may help patients avoid or delay chemotherapy while controlling their cancer.
This trial is testing whether giving radiation therapy after surgery can help prevent lung cancer from coming back in people who have already had chemotherapy and immunotherapy before surgery. It is for patients whose cancer had spread to chest lymph nodes and who still have some cancer left in those nodes after surgery.
Hear when a new Lung Cancer (NSCLC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.